Ignite Creation Date:
2025-12-24 @ 7:07 PM
Ignite Modification Date:
2026-01-25 @ 4:47 AM
Study NCT ID:
NCT00838357
Status:
COMPLETED
Last Update Posted:
2015-03-24
First Post:
2009-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma).
Sponsor:
Genzyme, a Sanofi Company
Organization:
Conditions & Keywords Data
Conditions: